HUM — Humana Inc. stock price, charts and financials

QT78Humana Inc.

Humana Inc. (NYSE: HUM) is a Healthcare company in the Medical - Healthcare Plans industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
385.47
+0.47+0.12%
HUMQT78Humana Inc.·NYSE
385.47+0.12%
TA
Loading chart...
Signal & projected range
Analyst consensus risingHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
Snapshot
IndexS&P 500P/E36.15EPS (ttm)10.65Insider Own0.52%Shs Outstand120.08MPerf Week5.81%
Market Cap46.23BForward P/E23.18EPS next Y16.61Insider Trans0.13%Shs Float119.82MPerf Month-3.21%
Enterprise Value53.58BPEG-EPS next Q-0.83Inst Own74.98%Short Float3.55%Perf Quarter55.79%
Income1.28BP/S0.32EPS this Y-13.34%Inst Trans-Short Ratio2.63Perf Half Y98.92%
Sales145.69BP/B2.41EPS next Y81.49%ROA2.23%Short Interest4.25MPerf YTD50.31%
Book/sh-P/C-EPS next 5Y40.62%ROE6.91%52W High429.40 -10.23%Perf Year50.03%
Cash/sh-P/FCF-EPS past 3/5Y-23.62% -17.22%ROIC4.52%52W Low163.31 136.04%Perf 3Y-20.41%
Dividend Est.3.54 (0.92%)EV/EBITDA17.46Sales past 3/5Y11.75% 10.93%Gross Margin13.65%Volatility4.29% 4.16%Perf 5Y-9.59%
Dividend TTM3.54 (0.92%)EV/Sales0.37EPS Y/Y TTM5.81%Oper. Margin1.39%ATR (14)15.79Perf 10Y123.56%
Dividend Ex-DateJun 26, 2026Quick Ratio1.74Sales Y/Y TTM23.65%Profit Margin0.88%RSI (14)53.77Recom2.66
Dividend Gr. 3/5Y3.97% 7.20%Current Ratio1.74EPS Q/Q21.37%SMA20-0.12%Beta0.75Target Price416.78
Payout33.65%Debt/Eq0.74Sales Q/Q26.18%SMA502.88%Rel Volume0.88Prev Close385.00
Employees67,060LT Debt/Eq0.72EarningsNov 04SMA20043.78%Avg Volume1.57MPrice385.47
IPO DateDec 31, 1981Option/ShortYes / YesEPS/Sales Surpr.4.70% 0.71%Net Debt/EBITDA2.40Volume1,379,271Change0.12%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-04-26ReiteratedMorgan StanleyUnderweight$249$370
Jul-31-26ReiteratedBarclaysEqual Weight$344$407
Jul-30-26ReiteratedPiper SandlerNeutral$254$463
Jul-30-26ReiteratedOppenheimerOutperform$340$405
Jul-30-26ReiteratedRobert W. Baird$205$390
Jul-30-26ReiteratedLeerink PartnersMarket Perform$255$513
Jul-30-26DowngradeRaymond JamesOutperformMarket Perform
Jul-30-26ReiteratedGuggenheimBuy$269$471
Jul-30-26UpgradeEvercore ISI GroupIn LineOutperform$480
Jul-30-26ReiteratedUBSNeutral$320$405
Latest News
Aug-06-26
Aug-05-26
Aug-04-26
Aug-03-26
Aug-01-26
Jul-31-26
Jul-30-26
Jul-29-26
Company

Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.

Ownership
Total institutional ownership74.98%

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue145,679129,664117,811
Cost of Goods Sold Incl. D&A125,789110,812100,664
Gross Profit19,89018,85217,147
Selling, General and Administrative Excl. Other
3,97800
Research and Development
000
Other Operating Expense13,89017,39915,520
Operating Income2,0221,4531,627
Interest Expense704631660
Unusual Expense
Non-Operating Income (Expense)296631660
Net Income Before Taxes1,6141,4531,627
Income Taxes298250413
Consolidated Net Income1,2781,1881,207
Net Income From Continuing Operations1,3161,2031,214
Net Income1,2781,1881,207
EPS (Recurring)10.659.8710.01
EPS (Basic, Before Extraordinaries)10.659.8710.01
EPS (Diluted)10.569.849.98
EBITDA3,0692,9083,255
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio36.5026.0325.42
Price To Sales Ratio0.320.240.26
Gross Margin13.6514.5414.55
Operating Margin1.391.121.38
Net Margin0.880.921.02
Shares Outstanding120120121
Market Capitalization46,25630,73630,699
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$446.28$366.41$286.55$206.68$126.81 Close Price0.00K37.50K75.01K112.51K150.02KUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Shetty Sanjay KPresident, CenterWellApr 01 '26Option Exercise0.00887012,544Apr 03
Ventura Joseph CChief Legal OfficerFeb 24 '26Option Exercise0.001,035017,565Feb 26
Renaudin George IIPresident, InsuranceFeb 24 '26Option Exercise0.001,035016,494Feb 26
Felter John-Paul W.SVP, Chief Accting Off & Cont.Feb 24 '26Option Exercise0.0016507,568Feb 25
Shetty Sanjay KPresident, CenterWellFeb 23 '26Buy185.21810150,01611,657Feb 25
Dintenfass DavidPresident, Enterprise GrowthFeb 21 '26Option Exercise0.003,858015,316Feb 24
Mellet CelesteChief Financial OfficerFeb 13 '26Option Exercise0.007,763028,454Feb 18
Mehta JapanChief Information OfficerFeb 13 '26Option Exercise0.001,68208,158Feb 18
Rechtin James A.President & CEOJan 08 '26Option Exercise0.002,183029,285Jan 12
O'Hara Michelle A.Chief Human Resources OfficerJan 01 '26Option Exercise0.002,353010,634Jan 05
Mellet CelesteChief Financial OfficerDec 15 '25Option Exercise0.002,128029,676Dec 17
Mehta JapanChief Information OfficerDec 15 '25Option Exercise0.001,19408,628Dec 17
Dintenfass DavidPresident, Enterprise GrowthDec 15 '25Option Exercise0.002,032016,234Dec 17
Shetty Sanjay KPresident, CenterWellDec 15 '25Option Exercise0.002,276011,566Dec 17
O'Hara Michelle A.Chief Human Resources OfficerDec 15 '25Option Exercise0.001,401011,266Dec 17
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.